DaVita (NYSE:DVA) Upgraded at StockNews.com

StockNews.com upgraded shares of DaVita (NYSE:DVA) from a buy rating to a strong-buy rating in a research report report published on Thursday morning.

DVA has been the topic of a number of other reports. Truist Financial boosted their price objective on DaVita from $130.00 to $135.00 and gave the company a hold rating in a research report on Tuesday, February 20th. TheStreet upgraded shares of DaVita from a c+ rating to a b- rating in a research note on Wednesday, February 7th. UBS Group lifted their target price on shares of DaVita from $113.00 to $134.00 and gave the company a buy rating in a research report on Wednesday, February 14th. Finally, Barclays began coverage on shares of DaVita in a research note on Wednesday, March 6th. They issued an equal weight rating and a $133.00 target price on the stock. Two investment analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of Moderate Buy and a consensus target price of $118.50.

DaVita Stock Up 0.6 %

Shares of DaVita stock opened at $133.51 on Thursday. The company has a quick ratio of 1.13, a current ratio of 1.19 and a debt-to-equity ratio of 6.65. DaVita has a 12-month low of $71.51 and a 12-month high of $141.54. The stock has a 50 day moving average price of $132.12 and a two-hundred day moving average price of $110.85. The stock has a market capitalization of $11.71 billion, a P/E ratio of 18.04, a PEG ratio of 1.19 and a beta of 1.04.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, February 13th. The company reported $1.87 EPS for the quarter, beating analysts’ consensus estimates of $1.53 by $0.34. DaVita had a net margin of 5.70% and a return on equity of 64.42%. The business had revenue of $3.15 billion during the quarter, compared to analyst estimates of $3.01 billion. During the same quarter in the prior year, the business earned $1.11 earnings per share. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. Equities analysts expect that DaVita will post 9.23 earnings per share for the current year.

Insider Transactions at DaVita

In other news, CEO Javier Rodriguez sold 67,603 shares of DaVita stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the completion of the sale, the chief executive officer now owns 488,697 shares in the company, valued at approximately $61,629,578.67. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other DaVita news, COO Michael David Staffieri sold 29,488 shares of the company’s stock in a transaction that occurred on Wednesday, February 21st. The shares were sold at an average price of $119.81, for a total value of $3,532,957.28. Following the completion of the sale, the chief operating officer now owns 37,687 shares of the company’s stock, valued at $4,515,279.47. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Javier Rodriguez sold 67,603 shares of DaVita stock in a transaction on Monday, February 26th. The stock was sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the transaction, the chief executive officer now directly owns 488,697 shares in the company, valued at $61,629,578.67. The disclosure for this sale can be found here. Insiders sold a total of 134,540 shares of company stock worth $16,551,071 over the last 90 days. 1.40% of the stock is owned by insiders.

Institutional Trading of DaVita

Hedge funds have recently added to or reduced their stakes in the business. Checchi Capital Advisers LLC acquired a new stake in shares of DaVita during the first quarter worth about $244,000. Equitable Trust Co. raised its holdings in DaVita by 47.2% during the 1st quarter. Equitable Trust Co. now owns 40,136 shares of the company’s stock worth $5,541,000 after buying an additional 12,871 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its stake in DaVita by 13.3% in the first quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 11,039 shares of the company’s stock valued at $1,524,000 after buying an additional 1,300 shares in the last quarter. Wedge Capital Management L L P NC boosted its holdings in shares of DaVita by 8.2% in the first quarter. Wedge Capital Management L L P NC now owns 334,231 shares of the company’s stock valued at $46,141,000 after buying an additional 25,372 shares during the period. Finally, Nilsine Partners LLC increased its position in shares of DaVita by 1.8% during the first quarter. Nilsine Partners LLC now owns 11,038 shares of the company’s stock worth $1,524,000 after acquiring an additional 193 shares in the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.